HAVN Life Sciences Inc.
OTC: HAVLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tim Moore
- Employees
- 6
- Headquarters
- Port Moody, Canada
- IPO year
- 2021
- Market cap
- $2.6K
- Website
- https://www.havnlife.com
Loading HAVLF…
Loading profile data…Frequently asked questions about HAVLF
What does HAVN Life Sciences Inc. (HAVLF) do?
HAVN Life Sciences Inc. is a biotechnology firm that specializes in the research and innovation of psychotropic compounds derived from botanical and fungal organisms. The company is also dedicated to establishing standardized, quality-controlled methodologies for extracting these psychoactive molecules, with a specific focus on Psilocybe mushroo...
Where does HAVLF trade?
HAVN Life Sciences Inc. (HAVLF) trades on the Other OTC.
What sector is HAVLF in?
HAVN Life Sciences Inc. (HAVLF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of HAVN Life Sciences Inc.?
Tim Moore is the chief executive officer of HAVN Life Sciences Inc. (HAVLF).
Where is HAVN Life Sciences Inc. headquartered?
HAVN Life Sciences Inc. is headquartered in Canada.
Does HAVLF pay a dividend?
HAVN Life Sciences Inc. (HAVLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HAVLF go public?
HAVN Life Sciences Inc. (HAVLF) completed its initial public offering in 2021.